Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-06-20T15:47:52.076Z Has data issue: false hasContentIssue false

Evaluation of H19, Mest, Meg3, and Peg3 genes affecting growth and metabolism in umbilical cord blood cells of infants born to mothers with gestational diabetes and healthy mothers in Rafsanjan City, Iran

Published online by Cambridge University Press:  29 July 2022

Fatemeh Rahimi Mehdi Abad
Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Mohammad Reza Hajizadeh*
Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Mehdi Mahmoodi
Department of Clinical Biochemistry, Afzalipoor Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
Zahra Jalali
Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Fatemeh Nazem Kazeruni
Department of Obstetrics and Gynecology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Jennifer Swann
Biological Sciences, Interim Director of Africana Studies, Williams Hall, Lehigh University, Bethlehem, United States
Reza Hosseiniara
Department of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Mojgan Noroozi Karimabad
Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Science, Rafsanjan, Iran
Address for correspondence: Dr. Mohammad Reza Hajizadeh, Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Email:


Hyperglycemia during the first trimester leads to an increased risk of innate malformations as well as death at times close to delivery dates. The methylated genes include those from paternal H19 and PEG3 and those from maternal MEST and MEG3 that are necessary for the growth and regulation of the human fetus and its placenta. The aim of this study was to evaluate and compare the expression of these genes in the cord blood of healthy infants born to mothers with gestational diabetes mellitus (GDM) and healthy mothers.

This case-control study was conducted on the cord blood of 40 infants born to mothers with GDM and 35 infants born to healthy mothers. Mothers were identified by measuring oral glucose tolerance in the 24th–26th week of pregnancy. Cord blood was obtained post-delivery, and cord blood mononuclear cells were immediately extracted, using Ficoll solution. Then, RNA extraction and cDNA synthesis were performed, and gene expression of MEG3, PEG3, H19, and MEST was assessed through quantitative real-time PCR.

Findings show that the expression levels of MEG3, PEG3, H19, and MEST genes were significantly decreased in mononuclear cord blood cells of infants born to mothers with GDM when compared to those of the healthy control group.

These findings reveal that the reduction of imprinted genes in mothers with GDM is most likely due to changes in their methylation by an epigenetic process. Considering the importance of GDM due to its high prevalence and its side effects both for mother and fetus, recognizing their exact mechanisms is of high importance. This has to be studied more widely.

Original Article
© The Author(s), 2022. Published by Cambridge University Press in association with International Society for Developmental Origins of Health and Disease

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)


Sweeney, A, Brown, F. Gestational diabetes mellitus. Clin Lab Med. 2001; 21 1, 173192.Google Scholar
Jafari-Shobeiri, M, Ghojazadeh, M, Azami-Aghdash, S, et al. Prevalence and risk factors of gestational diabetes in Iran: a systematic review and meta-analysis. Iran J Public Health. 2015; 44(8), 10361044.Google ScholarPubMed
Jovanovic, L, Peterson, CM. Screening for gestational diabetes: optimum timing and criteria for retesting. Diabetes. 1985; 34(Supplement 2), 2123. DOI 10.2337/diab.34.2.S21.CrossRefGoogle ScholarPubMed
Derakhshan, R, Raeisi, N, Sadeghi, T. Prevalence of congenital heart disease and related factors among children admitted to the pediatric cardiac center in Rafsanjan, Southeastern Iran. Nov Clin Med. 2022; 1(3), 121126. DOI 10.22034/ncm.2022.336934.1037.Google Scholar
Johns, EC, Denison, FC, Norman, JE, Reynolds, RM. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab. 2018; 29(11), 743754. DOI 10.1016/j.tem.2018.09.004.CrossRefGoogle ScholarPubMed
Acar, N, Korgun, ET, Cayli, S, Sahin, Z, Demir, R, Ustunel, I. Is there a relationship between PCNA expression and diabetic placental development during pregnancy? Acta Histochem. 2008; 110(5), 408417. DOI 10.1016/j.acthis.2007.11.011.CrossRefGoogle Scholar
Ahangari, T, Ebrahimi, K, Salari Lak, S. Estimating attributable mortality of modifying selected risk factors of myocardial infarction. Nov Clin Med. 2022; 1(1), 3843. DOI 10.22034/ncm.2022.140807.Google Scholar
Kulkarni, SR, Kumaran, K, Rao, SR, et al. Maternal lipids are as important as glucose for fetal growth: findings from the Pune Maternal Nutrition Study. Diabetes Care. 2013; 36(9), 27062713.CrossRefGoogle ScholarPubMed
Schaefer-Graf, UM, Buchanan, TA, Xiang, A, Songster, G, Montoro, M, Kjos, SL. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol. 2000; 182(2), 313320. DOI 10.1016/S0002-9378(00)70217-1.CrossRefGoogle ScholarPubMed
Gagné-Ouellet, V, Houde, A-A, Guay, S-P, et al. Placental lipoprotein lipase DNA methylation alterations are associated with gestational diabetes and body composition at 5 years of age. Epigenetics. 2017; 12(8), 616625. DOI 10.1080/15592294.2017.1322254 PMid: 28486003. PMCid: PMC5687327.CrossRefGoogle ScholarPubMed
Barker, DJP. The origins of the developmental origins theory. J Intern Med. 2007; 261(5), 412417. DOI 10.1111/j.1365-2796.2007.01809.x PMid:17444880.CrossRefGoogle ScholarPubMed
Bateson, P, Barker, D, Clutton-Brock, T, et al. Developmental plasticity and human health. Nature. 2004; 430(6998), 419421. DOI 10.1038/nature02725.CrossRefGoogle ScholarPubMed
Kanwar, YS, Pan, X, Lin, S, et al. Imprinted mesodermal specific transcript (MEST) and H19 genes in renal development and diabetes. Kidney Int. 2003; 63(5), 16581670. DOI 10.1046/j.1523-1755.2003.00905.x PMid:12675841.CrossRefGoogle ScholarPubMed
Shao, WJ, Tao, LY, Gao, C, et al. Alterations in methylation and expression levels of imprinted genes H19 and Igf2 in the fetuses of diabetic mice. Comp Med. 2008; 58(4), 341346.Google ScholarPubMed
O’Neill, K, Alexander, J, Azuma, R, et al. Gestational diabetes alters the metabolomic profile in 2nd trimester amniotic fluid in a sex-specific manner. Int J Mol Sci. 2018; 19(9), 2696.CrossRefGoogle Scholar
D’Anna, R, Baviera, G, Cannata, ML, De Vivo, A, Di Benedetto, A, Corrado, F. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes. Gynecol Obstet Investig. 2007; 64(2), 6568.CrossRefGoogle ScholarPubMed
Ariel, I, Miao, HQ, Ji, XR, et al. Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Mol Pathol. 1998; 51(1), 2125. DOI 10.1136/mp.51.1.21 PMid: 9624415. PMCid: PMC395603.CrossRefGoogle ScholarPubMed
Pope, C, Mishra, S, Russell, J, Zhou, Q, Zhong, XB. Targeting H19, an imprinted long non-coding RNA, in hepatic functions and liver diseases. Diseases. 2017; 5(1), 11.CrossRefGoogle ScholarPubMed
Kameswaran, V, Golson, ML, Ramos-Rodríguez, M, et al. The dysregulation of the DLK1-MEG3 locus in islets from patients with type 2 diabetes is mimicked by targeted epimutation of its promoter with TALE-DNMT constructs. Diabetes. 2018; 67(9), 18071815. DOI 10.2337/db17-0682.CrossRefGoogle ScholarPubMed
Birney, E, Stamatoyannopoulos, JA, Dutta, A, et al. Identification and analysis of functional elements in of the human genome by the ENCODE pilot project. Nature. 2007; 447(7146), 799816. DOI 10.1038/nature05874 PMid: 17571346. PMCid: PMC2212820.Google ScholarPubMed
Rocha, STda, Edwards, CA, Ito, M, Ogata, T, Ferguson-Smith, AC. Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet. 2008; 24(6), 306316. DOI 10.1016/j.tig.2008.03.011.CrossRefGoogle ScholarPubMed
Heijmans, BT, Tobi, EW, Stein, AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA. 2008; 105(44), 1704617049. DOI 10.1073/pnas.0806560105 PMid: 18955703. PMCid: PMC2579375.CrossRefGoogle ScholarPubMed
Leach, L, Taylor, A, Sciota, F. Vascular dysfunction in the diabetic placenta: causes and consequences. J Anat. 2009; 215(1), 6976. DOI 10.1111/j.1469-7580.2009.01098.x PMid: 19563553. PMCid: PMC2714640.CrossRefGoogle ScholarPubMed
Zhang, J, Lin, Z, Gao, Y, Yao, T. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer. J Exp Clin Cancer Res. 2017; 36(1), 5. DOI 10.1186/s13046-016-0472-2 PMid: 28057015. PMCid: PMC5216566.CrossRefGoogle ScholarPubMed
Kameswaran, V, Bramswig, NC, McKenna, LB, et al. Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab. 2014; 19(1), 135145. DOI 10.1016/j.cmet.2013.11.016 PMid: 24374217. PMCid: PMC3932527.CrossRefGoogle ScholarPubMed
You, L, Wang, N, Yin, D, et al. Downregulation of long noncoding RNA Meg3 affects insulin synthesis and secretion in mouse pancreatic beta cells. J Cell Physiol. 2016; 231(4), 852862. DOI 10.1002/jcp.25175.CrossRefGoogle ScholarPubMed
Sellers, ZP, Bolkun, L, Kloczko, J, et al. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival. Clin Epigenetics. 2019; 11(1), 50. DOI 10.1186/s13148-019-0643-z PMid: 30876483. PMCid: PMC6419839.CrossRefGoogle ScholarPubMed
Qiu, G-Z, Tian, W, Fu, H-T, Li, C-P, Liu, B. Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction. Biochem Biophys Res Commun. 2016; 471(1), 135141. DOI 10.1016/j.bbrc.2016.01.164.CrossRefGoogle ScholarPubMed
Che, X, Deng, X, Xie, K, et al. Long noncoding RNA MEG3 suppresses podocyte injury in diabetic nephropathy by inactivating Wnt/β-catenin signaling. PeerJ. 2019; 7(1), e8016e8016. DOI 10.7717/peerj.8016 PMid: 31799068. PMCid: PMC6885352.CrossRefGoogle ScholarPubMed
Huynh, J, Yamada, J, Beauharnais, C, et al. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion. Placenta. 2015; 36(10), 11611166. DOI 10.1016/j.placenta.2015.08.004 PMid: 26303757. PMCid: PMC4609602.CrossRefGoogle ScholarPubMed
Ge, Z-J, Liang, Q-X, Luo, S-M, et al. Diabetic uterus environment may play a key role in alterations of DNA methylation of several imprinted genes at mid-gestation in mice. Reprod Biol Endocrinol RBE. 2013; 11(1), 119. DOI 10.1186/1477-7827-11-119 PMid: 24378208. PMCid: PMC3896855.CrossRefGoogle ScholarPubMed
Miyoshi, N, Wagatsuma, H, Wakana, S, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000; 5(3), 211220. DOI 10.1046/j.1365-2443.2000.00320.x.CrossRefGoogle ScholarPubMed
Fauque, P, Ripoche, M-A, Tost, J, et al. Modulation of imprinted gene network in placenta results in normal development of in vitro manipulated mouse embryos. Hum Mol Genet. 2010; 19(9), 17791790. DOI 10.1093/hmg/ddq059.CrossRefGoogle ScholarPubMed
Houde, AA, St-Pierre, J, Hivert, MF, et al. Placental lipoprotein lipase DNA methylation levels are associated with gestational diabetes mellitus and maternal and cord blood lipid profiles. J Dev Orig Health Dis. 2014; 5(2), 132141. DOI 10.1017/S2040174414000038.CrossRefGoogle ScholarPubMed